Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$32.76 - $39.56 $1.18 Million - $1.43 Million
36,033 Added 1.33%
2,751,705 $96.2 Million
Q4 2023

Feb 13, 2024

BUY
$14.5 - $38.0 $2.55 Million - $6.68 Million
175,899 Added 6.93%
2,715,672 $103 Million
Q3 2023

Nov 13, 2023

SELL
$15.75 - $26.31 $107,572 - $179,697
-6,830 Reduced 0.27%
2,539,773 $46.6 Million
Q2 2023

Aug 11, 2023

BUY
$16.96 - $27.82 $3.62 Million - $5.94 Million
213,678 Added 9.16%
2,546,603 $66.1 Million
Q1 2023

May 12, 2023

SELL
$18.45 - $27.14 $1.54 Million - $2.26 Million
-83,263 Reduced 3.45%
2,332,925 $44 Million
Q4 2022

Feb 13, 2023

BUY
$20.18 - $33.33 $4.55 Million - $7.52 Million
225,670 Added 10.3%
2,416,188 $59.5 Million
Q3 2022

Nov 14, 2022

BUY
$11.58 - $24.73 $2.47 Million - $5.28 Million
213,407 Added 10.79%
2,190,518 $39.3 Million
Q2 2022

Aug 12, 2022

BUY
$8.52 - $25.26 $638,693 - $1.89 Million
74,964 Added 3.94%
1,977,111 $22.4 Million
Q1 2022

May 12, 2022

BUY
$19.89 - $43.18 $152,755 - $331,622
7,680 Added 0.41%
1,902,147 $42.4 Million
Q4 2021

Feb 10, 2022

BUY
$26.75 - $46.02 $6.2 Million - $10.7 Million
231,936 Added 13.95%
1,894,467 $82.7 Million
Q3 2021

Nov 09, 2021

BUY
$25.18 - $37.81 $4.16 Million - $6.25 Million
165,358 Added 11.04%
1,662,531 $55.4 Million
Q2 2021

Aug 11, 2021

BUY
$14.69 - $27.52 $22 Million - $41.2 Million
1,497,173 New
1,497,173 $41.2 Million

Others Institutions Holding INBX

# of Institutions
1
Shares Held
18.6K
Call Options Held
0
Put Options Held
0

About Inhibrx, Inc.


  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $570M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.